Page 36 - 2023-05-中国全科医学

2023年2月 第26卷 第5期 http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn ·549·

stroke［J］. Stroke，2014，45（9）：2599-2605. DOI： ［31］MAN-SON-HING M，NICHOL G，LAU A，et al. Choosing
10.1161/STROKEAHA.114.006070. antithrombotic therapy for elderly patients with atrial fibrillation who
［20］FILIPPATOS G，FARMAKIS D. A look back：the quest for are at risk for falls［J］. Arch Intern Med，1999，159（7）：
thrombosis in heart failure continues after COMMANDER HF［J］. 677-685. DOI：10.1001/archinte.159.7.677.
Cardiovasc Res，2019，115（13）：e140-142. DOI： ［32］JANUARY C T，WANN L S，ALPERT J S，et al. 2014 AHA/
10.1093/cvr/cvz241. ACC/HRS guideline for the management of patients with atrial
［21］SILLER-MATULA J M，PECEN L，PATTI G，et al. Heart failure fibrillation：executive summary：a report of the American College
subtypes and thromboembolic risk in patients with atrial fibrillation： of Cardiology/American Heart Association Task Force on practice
the PREFER in AF - HF substudy［J］. Int J Cardiol，2018， guidelines and the Heart Rhythm Society［J］. Circulation，2014，
265：141-147. DOI：10.1016/j.ijcard.2018.04.093. 130（23）：2071-2104. DOI：10.1161/cir.0000000000000040.
［22］GORST-RASMUSSEN A，SKJOTH F，LARSEN T B，et al. ［33］MELKONIAN M，JARZEBOWSKI W，PAUTAS E，et al.
Dabigatran adherence in atrial fibrillation patients during the first Bleeding risk of antiplatelet drugs compared with oral anticoagulants
year after diagnosis：a nationwide cohort study［J］. J Thromb in older patients with atrial fibrillation：a systematic review and
Haemost，2015，13（4）：495-504. DOI：10.1111/jth.12845. meta-analysis［J］. J Thromb Haemost，2017，15（7）：1500-
［23］MAZUREK M，HUISMAN M V，LIP G Y H. Registries in 1510. DOI：10.1111/jth.13697.
atrial fibrillation：from trials to real-life clinical practice［J］. ［34］PONIKOWSKI P，VOORS A A，ANKER S D，et al. 2016 ESC
Am J Med，2017，130（2）：135-145. DOI：10.1016/j. Guidelines for the diagnosis and treatment of acute and chronic heart
amjmed.2016.09.012. failure：the Task Force for the diagnosis and treatment of acute and
［24］ZHENG H J，OUYANG S K，ZHAO Y，et al. The use status of chronic heart failure of the European Society of Cardiology （ESC）.
anticoagulation drugs for inpatients with nonvalvular atrial fibrillation Developed with the special contribution of the Heart Failure
in Southwest China［J］. Int J Gen Med，2017，10：69-77. Association （HFA） of the ESC［J］. Eur J Heart Fail，2016，
DOI：10.2147/IJGM.S128047. 18（8）：891-975. DOI：10.1002/ejhf.592.
［25］胡志成，蒋超，郑黎晖，等 . 2019 年中国心房颤动医疗质量控 ［35］WILTON S B，LEUNG A A，GHALI W A，et al. Outcomes
制报告［J］. 中国循环杂志，2020，35（5）：427-437. DOI: of cardiac resynchronization therapy in patients with versus
10.3969/j.issn.1000-3614.2020.05.003. those without atrial fibrillation：a systematic review and meta-
［26］JANUARY C T，WANN L S，CALKINS H，et al. 2019 AHA/ analysis［J］. Heart Rhythm，2011，8（7）：1088-1094. DOI：
ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for 10.1016/j.hrthm.2011.02.014.
the management of patients with atrial fibrillation：areport of the ［36］SAKATA Y，SHIMOKAWA H. Epidemiology of heart failure
American college of cardiology/American heart association task force in Asia［J］. Circ J，2013，77（9）：2209-2217. DOI：
on clinical practice guidelines and the heart rhythm society［J］. 10.1253/circj.cj-13-0971.
J Am Coll Cardiol，2019，74（1）：104-132. DOI：10.1016/j. ［37］BIASE L D，MOHANTY P，MOHANTY S，et al. Ablation versus
jacc.2019.01.011. amiodarone for treatment of persistent atrial fibrillation in patients
［27］GIUGLIANO R P，RUFF C T，BRAUNWALD E，et al. with congestive heart failure and an implanted device：results
Edoxaban versus warfarin in patients with atrial fibrillation［J］. from the AATAC multicenter randomized trial［J］. Circulation，
N Engl J Med，2013，369（22）：2093-2104. DOI： 2016，133（17）：1637-1644. DOI：10.1161/CIRCULATIONA
10.1056/NEJMoa1310907. HA.115.019406.
［28］YUZAWA H，INOUE H，YAMASHITA T，et al. Rhythm versus ［38］闫静静，秦明照 . 中国老年心房颤动患者抗凝治疗现状及分
rate control strategies regarding anticoagulant use in elderly non- 析［J］. 中国全科医学，2018，21（27）：3285-3289. DOI：
valvular atrial fibrillation patients：Subanalysis of the ANAFIE （All 10.12114/j.issn.1007-9572.2018.00.079.
Nippon AF in the Elderly） Registry［J］. J Cardiol，2020，76（1）： YAN J J，QIN M Z. Anticoagulation therapy for Chinese elderly
87-93. DOI：10.1016/j.jjcc.2020.01.010. patients with atrial fibrillation［J］. Chinese General Practice，
［29］EIKELBOOM J W，CONNOLLY S J，BRUECKMANN M，et al. 2018，21（27）：3285-3289. DOI：10.12114/j.issn.1007-
Dabigatran versus warfarin in patients with mechanical 9572.2018.00.079.
heart valves［J］. N Engl J Med，2013，369（13）：1206- ［39］CONTRERAS J P，HONG K N，CASTILLO J，et al.
1214. DOI：10.1056/NEJMoa1300615. Anticoagulation in patients with atrial fibrillation and heart failure：
［30］BAIY，GUO S D，DENG H，et al. Effectiveness and safety of oral insights from the NCDR PINNACLE-AF registry［J］. Clin
anticoagulants in older patients with atrial fibrillation：a systematic Cardiol，2019，42（3）：339-345. DOI：10.1002/clc.23142.
review and meta-regression analysis［J］. Age Ageing，2018，47 （收稿日期：2022-06-11；修回日期：2022-08-15）
（1）：9-17. DOI：10.1093/ageing/afx103. （本文编辑：崔莎）